shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    Developing and Testing Pilot Prevention Interventions to Reduce Sexual Risk Behavior and Enhance PrEP Use among HIV-negative Black and Hispanic Substance-using Gay, Bisexual, and Other MSM

    RFA-PS-25-113

    Amy Yang

    Opening date 6 Aug 2024, 12:00AM

    Closing date N/A

    Funding Opportunity Number: RFA-PS-25-113

    Opportunity Category: Discretionary

    Expected Number of Awards: 2

    CFDA Number(s): 93.084 -- Prevention of Disease, Disability, and Death by Infectious Diseases

    Cost Sharing or Matching Requirement: No

    Posted Date: Aug 06, 2024 12:00:00 AM EDT

    Closing Date: N/A

    Estimated Total Program Funding: 2850000

    Award Ceiling: $475000

    Award Floor: $400000

    Eligible Applicants: Private institutions of higher education,City or township governments,Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education,Special district governments,Independent school districts,State governments,Public housing authorities/Indian housing authorities,Native American tribal organizations (other than Federally recognized tribal governments),For profit organizations other than small businesses,County governments,Public and State controlled institutions of higher education,Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education,Native American tribal governments (Federally recognized)

    Description: This notice of funding opportunity (NOFO) supports investigator-driven research and invites recipients to conceive, design, develop, direct, and conduct data collection to meet the project goals outlined herein. The NOFO purpose is to support pilot research to develop and test two (2) behavioral interventions to enhance HIV and STI prevention implementation (PrEP, condoms) among HIV-negative gay, bisexual and other men who have sex with men (MSM), one (1) award for Black/African American (Black) MSM and one (1) award for Hispanic/Latino (Hispanic) MSM who report substance (drug or alcohol) use before or during unprotected (condom-less and Prep-less) anal sex with a non-primary male partner in the past 3 months (herein substance-using MSM, SUMSM). Each application should be for one of the two groups. The study design and required sample size will meet minimum requirements for consideration of the CDC Compendium of Best Evidence (CDC, 2023), and thus may have the potential for future CDC HIV prevention funding implementation in jurisdictions around the United States. The research sites must be priority jurisdictions outlined in Ending the HIV Epidemic in the United States (EHE) (CDC, 2024), in support of the goals of EHE, the National Strategic Plan, and other federal prevention planning efforts.

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept